Floatz logo

Acetylsalicylic Acid

Brain Infarction

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Brain Infarction cohort.

Asset / SponsorPhaseRating
Recombinant Human Plasminogen Activator
Nippon Medical School
Phase 4BB
3-N-BUTYLPHTHALIDE
Qianfoshan Hospital
Phase 4BB
WARFARIN
Assistance Publique - Hôpitaux de Paris
Phase 3BB
Recombinant Human Plasminogen Activator
Nippon Medical School
Phase 4BB
Eptifibatide
Arthur Pancioli
Phase 2B

View all 14 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →